Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5449]

Treatment of metastatic NSCLC without PD-L1 expression and without oncogene...

Dr Antonio Passaro - European Institute of Oncology, Milan, Italy

Treatment of metastatic NSCLC without PD-L1 expression and without oncogene addiction ( Dr Antonio Passaro - European Institute of Oncology, Milan, Italy )

Personalised systemic treatment in advanced prostate cancer

Dr Karim Fizazi - Institute Gustave Roussy, Villejuif, France

Personalised systemic treatment in advanced prostate cancer ( Dr Karim Fizazi - Institute Gustave Roussy, Villejuif, France )

Multiple myeloma treatment in Dakar: Epidemiological, diagnostic, and...

Dr Nata Dieng - Hôpital Principal de Dakar, Dakar, Senegal

Multiple myeloma treatment in Dakar: Epidemiological, diagnostic, and therapeutic aspects ( Dr Nata Dieng - Hôpital Principal de Dakar, Dakar, Senegal )

Nivolumab plus ipilimumab improves on chemo in previously untreated MSI-H/dMMR...

Dr Thierry André - Sorbonne Université, Paris, France

Nivolumab plus ipilimumab improves on chemo in previously untreated MSI-H/dMMR mCRC ( Dr Thierry André - Sorbonne Université, Paris, France )

Applying Choosing Wisely in radiation oncology in Africa

Dr Melinda Mushonga - Kingston General Hospital, Kingston, Canada

Applying Choosing Wisely in radiation oncology in Africa ( Dr Melinda Mushonga - Kingston General Hospital, Kingston, Canada )

Adding atezolizumab to adjuvant chemotherapy for stage II and III triple...

Dr Michail Ignatiadis - Institut Jules Bordet, Brussels, Belgium

Adding atezolizumab to adjuvant chemotherapy for stage II and III triple-negative breast cancer is unlikely to improve efficacy ( Dr Michail Ignatiadis - Institut Jules Bordet, Brussels, Belgium )

Implementation Science: An emerging role for strengthening cancer control...

Dr Nwamaka Lasebikan - University of Nigeria Teaching Hospital, Ituku-Ozalia...

Implementation Science: An emerging role for strengthening cancer control efforts in Africa ( Dr Nwamaka Lasebikan - University of Nigeria Teaching Hospital, Ituku-Ozalia, Nigeria )

Implementation of Choosing Wisely in Rwanda, Tanzania and Ghana

Dr Sarah Kutika Nyagabona - Muhimbili National Hospital, Dar es Salaam, Tanzania

Implementation of Choosing Wisely in Rwanda, Tanzania and Ghana ( Dr Sarah Kutika Nyagabona - Muhimbili National Hospital, Dar es Salaam, Tanzania )

The quantification of cancer medicines in Zambia

Dr Susan Citonje Msadabwe - Cancer Diseases Hospital, Lusaka, Zambia

The quantification of cancer medicines in Zambia ( Dr Susan Citonje Msadabwe - Cancer Diseases Hospital, Lusaka, Zambia )

The treatment of cervical cancer in the presence of HIV in Sub-Saharan Africa

Dr Ntokozo Ndlovu - University of Zimbabwe, Harare, Zimbabwe

The treatment of cervical cancer in the presence of HIV in Sub-Saharan Africa ( Dr Ntokozo Ndlovu - University of Zimbabwe, Harare, Zimbabwe )

Vitamin D in patients with low tumour-burden indolent non-Hodgkin lymphoma...

Dr Jonathan Friedberg - University of Rochester, Rochester, USA

Vitamin D in patients with low tumour-burden indolent non-Hodgkin lymphoma treated with rituximab therapy ( Dr Jonathan Friedberg - University of Rochester, Rochester, USA )

Choosing Wisely conferences: Lessons learned and the way forward

Dr Omar Abdihamid - Garissa Cancer Centre, Garissa, Kenya

Choosing Wisely conferences: Lessons learned and the way forward ( Dr Omar Abdihamid - Garissa Cancer Centre, Garissa, Kenya )

More from ecancer